We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLNG:NASDAQStabilis Solutions, Inc. Analysis

Data as of 2026-09-02 - not real-time

$6.59

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $6.59, Stabilis Solutions, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. It has gained 88.3% over the past 30 days. RSI sits at 70.5, which reads as overbought, and MACD momentum is bullish. The recent range runs from support at $4.60 up to resistance at $7.07.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 36.6% above today's level. Revenue is contracting at 31.2% on a -14.1% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 109.3%, a beta of -0.25 and a maximum drawdown of 45.1%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top Market Events

$100M data center contract signals strong 2027 growth despite 31% revenue decline.HOUSTON, TX / ACCESS Newswire / August 11, 2026 / Stabilis Solutions, Inc.Seeking Alpha20dStabilis Solutions, Inc. SLNG Q2 2026 Earnings Call TranscriptI would now like to turn our call over to...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 70.5 signals overbought conditions
  • Trading above the 200-day average of 4.58

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 70.5 signals overbought conditions
  • Trading above the 200-day average of 4.58

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Negative profit margin of -14.1%
  • Analyst targets imply +36.6% versus the current price
  • Negative return on equity of -12.7%

Key Metrics & Analysis

Financial Health

Revenue Growth-31.20%
Profit Margin-14.06%
P/E Ratio-109.8
ROE-12.68%
ROA-6.06%
Debt/Equity14.07
P/B Ratio2.1
Op. Cash Flow$22.5M
Free Cash Flow$-22745250
Industry P/E21.8

Technical Analysis

TrendBullish
RSI70.5
Support$4.60
Resistance$7.07
MA 20$5.60
MA 50$4.77
MA 200$4.58
MACDBullish
VolumeDecreasing
Fear & Greed Index92.25

Valuation

Fair Value$10.58
Target Price$9.00
Upside/Downside36.57%
GradeFair
TypeBlend

Risk Assessment

Beta-0.25
Volatility109.34%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.